优化儿科急诊肺炎与鼻窦炎抗生素疗程
该质量改进项目旨在将儿科急诊社区获得性肺炎(CAP)和急性细菌性鼻窦炎(ABRS)出院患儿接受最佳抗生素疗程的比例从13%提升至70%。通过临床路径、电子健康记录更新和处方者教育等干预, outcome指标中心线从13.1%升至64.8%,且14天内同诊断复诊数无变化。
要点
- 指南推荐无并发症CAP抗生素疗程3至5天,ABRS为5至7天。
- 质量改进干预使最佳疗程比例从13.1%升至64.8%。
- 14天内同诊断复诊数作为平衡指标未见变化。
核心结论
- 通过临床路径、电子健康记录更新、处方者教育与反馈及资源分发,显著改善了CAP和ABRS的抗生素处方疗程。
研究设计与样本
- 质量改进项目,组建多学科团队,使用因果分析、驱动图和优先矩阵等工具,并调查处方者对短疗程的接受度。
- 实施计划-执行-研究-行动(PDSA)循环,包括新临床路径、电子健康记录更新和处方者教育。
主要发现
- 这些变化主要反映CAP疗程,因为CAP是更常见的诊断,但ABRS短疗程在此期间也显示类似改善。
- 过程指标随时间增加,平衡指标(14天内同诊断复诊数)无变化。
关键数值与推荐
- 国家及国际指南更新推荐无并发症CAP抗生素疗程缩短至3至5天。
- 国家及国际指南更新推荐ABRS抗生素疗程为5至7天。
临床怎么用
- 在儿科急诊对CAP和ABRS患儿可采纳短疗程抗生素方案,并利用临床路径和电子健康记录工具支持实施。
- 通过处方者教育与反馈促进短疗程指南的落地,同时监测14天内同诊断复诊情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Updates to national and international guidelines now recommend shortening antibiotic durations to 3 to 5 days for uncomplicated community-acquired pneumonia (CAP) and 5 to 7 days for acute bacterial rhinosinusitis (ABRS). We aimed to increase the percentage of children discharged home from the emergency department with CAP or ABRS who were treated with an optimal antibiotic duration from 13% to 70% by July 2025. METHODS: We assembled a multidisciplinary team and used quality improvement tools, including cause-and-effect analysis, driver diagram, and prioritization matrix, to identify impactful interventions. We also surveyed prescriber comfort with shorter antibiotic durations. Plan-Do-Study-Act cycles included implementing new clinical pathways (CP), electronic health record (EHR) updates, and educating prescribers. Our outcome metric was the percentage of patients receiving recommended antibiotic duration for CAP and ABRS. Process metrics included use of CP Quick Response codes and CAP "Quick-Discharge" order sets. Balancing metric was the number of return visits with the same diagnosis within 14 days. RESULTS: We saw shifts in the outcome metric center line in August 2023, February 2024, and November 2024 from 13.1% to 64.8%. These changes primarily reflected CAP duration because it was the more common diagnosis, although ABRS short antibiotic durations showed similar improvement during this time frame. Process metrics showed an increase over time. There was no change in balancing metric. CONCLUSION: We significantly improved antibiotic prescription durations for CAP and ABRS through CP changes, EHR updates, prescriber education and feedback, and resource distribution.
引用
- Saucedo JA, Hueschen LA, Nedved A, et al. Optimizing Antibiotic Duration for Pneumonia and Sinusitis in the Pediatric Emergency Department. Pediatrics. 2026. PMID: 42863842. doi:10.1542/peds.2026-076351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。